Hospira Cisplatin 100 mg/100 mL Solution for Infusion ONCO-TAIN

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

cisplatin, Quantity: 1 mg/mL

Inapatikana kutoka:

Hospira Australia Pty Ltd

INN (Jina la Kimataifa):

Cisplatin

Dawa fomu:

Injection, intravenous infusion

Tungo:

Excipient Ingredients: mannitol; sodium chloride; water for injections; hydrochloric acid; sodium hydroxide

Njia ya uendeshaji:

Intravenous Infusion

Vitengo katika mfuko:

1 x 100 mL

Darasa:

Medicine Listed (Export Only)

Dawa ya aina:

(S1) This Schedule is intentionally blank

Matibabu dalili:

Cisplatin is indicated for the treatment of: Metastatic non-seminomatous germ cell carcinoma Advanced and refractory carcinoma of the ovary; Advanced and refractory carcinoma of the bladder; Squamous cell carcinoma of the head and the neck.

Bidhaa muhtasari:

Visual Identification: A clear, colourless to pale yellow solution, free from visible particulates; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 2 Years; Container Temperature: Room temperature; Container Closure: Neither child resistant closure nor restricted flow insert

Idhini hali ya:

Licence status A

Idhini ya tarehe:

2009-03-27